Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses

Journal of Gene Medicine

Volumn 6, Issue 11, 2004, Pages 1197-1205

  Kuate, Seraphin ^a   Stefanou, Daniela ^a   Hoffmann, Dennis ^a   Wildner, Oliver ^a   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Gene transfer; Lentiviral vector; Packaging cells

Indexed keywords

ADENOVIRUS VECTOR; GAG PROTEIN; LENTIVIRUS VECTOR; POL PROTEIN; TETRACYCLINE; VIRUS DNA; VIRUS VECTOR;

ARTICLE; CELL CULTURE; CELL LINE; CLINICAL PROTOCOL; CODON; CONTROLLED STUDY; CYTOTOXICITY; DNA PACKAGING; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENETIC STABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROMOTER REGION; RISK REDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIROGENESIS; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS TITRATION;

ADENOVIRIDAE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; FUSION PROTEINS, GAG-POL; GENETIC VECTORS; HIV-1; HUMANS; PROMOTER REGIONS (GENETICS); SIMIAN IMMUNODEFICIENCY VIRUS; TETRACYCLINE; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 13644250074     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.623     Document Type: Article

References (32)

1. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
2. Reiser J, Harmison G, KluepfelStahl S, Brady RO, Karlson S, Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 1996; 93: 15266-15271.
3. Schnell T, Foley P, Wirth M, Münch J, Überla K. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther 2000; 11: 439-447.
4. Johnston JC, Gasmi M, Lim LE, et al. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 1999; 73: 4991-5000.
5. Mitrophanous KA, Yoon S, Rohll JB, et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 1999; 6: 1808-1818.
6. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998; 4: 354-357.
7. Wagner R, Graf M, Bieler K, et al. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther 2000; 11: 2403-2413.
8. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 2000; 74: 4839-4852.
9. Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM. A packaging cell line for lentivirus vectors. J Virol 1999; 73: 576-584.
10. Farson D, Witt R, McGuinness R, et al. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther 2001; 12: 981-997.
11. Pacchia AL, Adelson ME, Kaul M, Ron Y, Dougherty JP. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 2001; 282: 77-86.
12. Kuate S, Wagner R, Überla K. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors. J Gene Med 2002; 4: 347-355.
13. Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M. Continuous high-titer HIV-1 vector production. Nat Biotechnol 2003; 21: 569-572.
14. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis-virus G glycoprotein pseudotyped retroviral vectors - concentration to very high-titer and efficient gene-transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 1993; 90: 8033-8037.
15. Konvalinka J, Litterst MA, Welker R, et al. An active-site mutation in the human-immunodeficiency-virus type-1 proteinase (Pr) causes reduced Pr activity and loss of Pr-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J Virol 1995; 69: 7180-7186.
16. Yoshida Y, Emi N, Hamada H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression Biochem Biophys Res Commun 1997; 232: 379-382.
17. Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M, Blaese RM. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors Biochem Biophys Res Commun 1998; 246: 912-919.
18. Lin X. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Gene Ther 1998; 5: 1251-1258.
19. Duisit G, Salvetti A, Moullier P, Cosset FL. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum Gene Ther 1999; 10: 189-200.
20. Feng MZ, Jackson WH, Goldman CK, et al. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 1997; 15: 866-870.
21. Caplen NJ, Higginbotham JN, Scheel JR, et al. Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther 1999; 6: 454-459.
22. Russell WC. Update on adenovirus and its vectors. J Gene Virol 2000; 81: 2573-2604.
23. Charneau P, Mirambeau G, Roux P, Paulous S, Buc H, Clavel F. HIV-1 reverse transcription. A termination step at the center of the genome. J Mol. Biol 1994; 241: 651-662.
24. He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509-2514.
25. Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus Vector. J Virol 1998; 72: 8150-8157.
26. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996; 70: 7498-7509.
27. Chackerian B, Haigwood NL, Overbauch J. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 1995; 213: 386-394.
28. Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F. A molecular clone of HTLV-III with biological activity. Nature 1985; 316: 262-265.
29. Yao F, Svensjo T, Winkler T, Lu M, Eriksson C, Eriksson E. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 1998; 9: 1939-1950.
30. Nelson JE, Kay MA. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol 1997; 71: 8902-8907.
31. Steinwaerder DS, Carlson CA, Lieber A. DNA replication of first-generation adenovirus vectors in tumor cells. Hum Gene Ther 2000; 11: 1933-1948.
32. Kubo S, Mitani K. A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol 2003; 77: 2964-2971.